Mitsuyasu Tabo

400 total citations
24 papers, 267 citations indexed

About

Mitsuyasu Tabo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mitsuyasu Tabo has authored 24 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mitsuyasu Tabo's work include Cardiac electrophysiology and arrhythmias (13 papers), Ion channel regulation and function (9 papers) and Receptor Mechanisms and Signaling (5 papers). Mitsuyasu Tabo is often cited by papers focused on Cardiac electrophysiology and arrhythmias (13 papers), Ion channel regulation and function (9 papers) and Receptor Mechanisms and Signaling (5 papers). Mitsuyasu Tabo collaborates with scholars based in United States, Japan and Switzerland. Mitsuyasu Tabo's co-authors include Masaki Honda, Tomoaki Inoue, Kazuya Kimura, Shigeo Ito, Ryuichi Komatsu, Hitoshi Iikura, Toshiko Hara, Kazutomo Ori, Yuko Aoki and Naoki Harada and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Mitsuyasu Tabo

24 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuyasu Tabo United States 10 154 104 53 37 28 24 267
John Frazer United States 8 239 1.6× 46 0.4× 99 1.9× 30 0.8× 39 1.4× 15 361
M.G. Gruetter Switzerland 10 220 1.4× 62 0.6× 28 0.5× 61 1.6× 24 0.9× 12 348
S. Kalinka United Kingdom 7 177 1.1× 53 0.5× 58 1.1× 26 0.7× 12 0.4× 10 362
Jonas Hansen Denmark 12 351 2.3× 75 0.7× 158 3.0× 39 1.1× 59 2.1× 17 474
Dominic C. M. Ng United States 15 439 2.9× 54 0.5× 25 0.5× 22 0.6× 14 0.5× 25 595
Jampani Nageswara Rao United States 8 214 1.4× 67 0.6× 47 0.9× 14 0.4× 16 0.6× 8 423
Bjarne Due Larsen Denmark 12 375 2.4× 115 1.1× 15 0.3× 62 1.7× 35 1.3× 26 489
Wilhelmus E. A. de Witte Netherlands 10 211 1.4× 18 0.2× 59 1.1× 45 1.2× 53 1.9× 17 349
Aaron Kempema United States 10 264 1.7× 52 0.5× 31 0.6× 101 2.7× 10 0.4× 15 449
Zeynep Yurtsever United States 9 211 1.4× 43 0.4× 40 0.8× 19 0.5× 4 0.1× 12 309

Countries citing papers authored by Mitsuyasu Tabo

Since Specialization
Citations

This map shows the geographic impact of Mitsuyasu Tabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyasu Tabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyasu Tabo more than expected).

Fields of papers citing papers by Mitsuyasu Tabo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyasu Tabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyasu Tabo. The network helps show where Mitsuyasu Tabo may publish in the future.

Co-authorship network of co-authors of Mitsuyasu Tabo

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyasu Tabo. A scholar is included among the top collaborators of Mitsuyasu Tabo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyasu Tabo. Mitsuyasu Tabo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Mariko, Shunsuke Ito, Tomochika Matsushita, et al.. (2023). Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4 + T cell interleukin-2 secretion. mAbs. 15(1). 2253570–2253570. 3 indexed citations
2.
Honda, Masaki, Kenta Haraya, Yoshinori Narita, et al.. (2022). In vivo imaging with two-photon microscopy to assess the tumor-selective binding of an anti-CD137 switch antibody. Scientific Reports. 12(1). 4907–4907. 6 indexed citations
3.
Nakamura, Genki, et al.. (2021). Prediction of Human Pharmacokinetics Profile of Monoclonal Antibody Using hFcRn Transgenic Mouse Model. Biological and Pharmaceutical Bulletin. 44(3). 389–395. 5 indexed citations
4.
Ito, Shunsuke, Masayuki Mishima, Mariko Yano, et al.. (2019). In vitrohuman helper T-cell assay to screen antibody drug candidates for immunogenicity. Journal of Immunotoxicology. 16(1). 125–132. 20 indexed citations
5.
Harada, Asako, et al.. (2018). Different players generate positive responses in two in vitro cytokine assay formats with aqueous and immobilized TGN1412 analog. Biochemical and Biophysical Research Communications. 502(1). 91–97. 2 indexed citations
6.
Harada, Asako, Toshiko Hara, Tomoaki Inoue, et al.. (2016). Is an <i>in vitro</i> whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?. The Journal of Toxicological Sciences. 41(4). 523–531. 6 indexed citations
7.
Aoki, Toshihiro, Noriyuki Furuichi, Fumio Watanabe, et al.. (2014). Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning. ACS Medicinal Chemistry Letters. 5(4). 309–314. 15 indexed citations
8.
Honda, Masaki, et al.. (2014). Estimating the clinical risk of hypertension from VEGF signal inhibitors by a non-clinical approach using telemetered rats. The Journal of Toxicological Sciences. 39(2). 237–242. 7 indexed citations
9.
Honda, Masaki, et al.. (2013). Involvement of the Autonomic Nervous System in Diurnal Variation of Corrected QT Intervals in Common Marmosets. Journal of Pharmacological Sciences. 121(2). 131–137. 7 indexed citations
10.
Aoki, Toshihiro, Noriyuki Furuichi, Fumio Watanabe, et al.. (2013). The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6223–6227. 18 indexed citations
11.
Honda, Masaki, et al.. (2011). Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells. Journal of Pharmacological Sciences. 117(3). 149–159. 64 indexed citations
12.
Komatsu, Ryuichi, Masaki Honda, Henry H. Holzgrefe, et al.. (2010). Sensitivity of common marmosets to detect drug-induced QT interval prolongation: Moxifloxacin case study. Journal of Pharmacological and Toxicological Methods. 61(3). 271–276. 9 indexed citations
13.
Honda, Masaki, Ryuichi Komatsu, Henry H. Holzgrefe, et al.. (2010). Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets. Journal of Pharmacological and Toxicological Methods. 61(3). 264–270. 5 indexed citations
14.
Tabo, Mitsuyasu, Toshiko Hara, N. Shishido, et al.. (2008). Prediction of drug-induced QT interval prolongation in telemetered common marmosets. The Journal of Toxicological Sciences. 33(3). 315–325. 11 indexed citations
15.
Tabo, Mitsuyasu, et al.. (2008). Cardiovascular safety profile of MA-2029, a novel motilin receptor antagonist. The Journal of Toxicological Sciences. 33(5). 631–639. 2 indexed citations
16.
Kimura, Kazuya, Mitsuyasu Tabo, Atsuhiko Kato, et al.. (2007). HEMODYNAMIC AND ELECTROPHYSIOLOGICAL EFFECTS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN IN A HALOTHANE-ANESTHETIZED CANINE MODEL. The Journal of Toxicological Sciences. 32(3). 231–239. 4 indexed citations
17.
Kimura, Kazuya, Mitsuyasu Tabo, Atsuhiko Kato, et al.. (2007). PRECLINICAL ELECTROPHYSIOLOGY ASSAYS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN. The Journal of Toxicological Sciences. 32(3). 217–230. 4 indexed citations
18.
Tabo, Mitsuyasu, Kazuya Kimura, & Shigeo Ito. (2006). Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization. Journal of Pharmacological and Toxicological Methods. 55(3). 271–278. 11 indexed citations
19.
Tabo, Mitsuyasu, Mikiko Nakamura, Kazuya Kimura, & Shigeo Ito. (2006). QT-RR RELATIONSHIPS AND SUITABLE QT CORRECTION FORMULAS FOR HALOTHANE-ANESTHETIZED DOGS. The Journal of Toxicological Sciences. 31(4). 381–390. 7 indexed citations
20.
Tabo, Mitsuyasu, Toshio Ohta, Shigeo Ito, & Yoshikazu Nakazato. (1996). Effects of external K+ on depletion-induced Ca2+ entry in rat ileal smooth muscle. European Journal of Pharmacology. 313(1-2). 151–158. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026